Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value

$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck consolidated EMEA Revenue ($M) ($M)

Postgres DB segment_values

Quarterly Annual

Latest, FY2025

14,580

Period ended Dec 31, 2025

Change on a year earlier

+3.8%

14,041 in FY2024

History

15 years

Since FY2011

Sources

Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Consolidated EMEA Revenue ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	14,580	+3.8%	Form 10-K (filed 2026-02-24) ↗
FY2024	Dec 31, 2024	14,041	+5.9%	Form 10-K (filed 2025-02-25) ↗
FY2023	Dec 31, 2023	13,254	-8.5%	Form 10-K (filed 2024-02-26) ↗
FY2022	Dec 31, 2022	14,493	+8.6%	Form 10-K (filed 2023-02-24) ↗
FY2021	Dec 31, 2021	13,341	+15.5%	Form 10-K (filed 2022-02-25) ↗
FY2020	Dec 31, 2020	11,547	+10.0%	Form 10-K (filed 2022-02-25) ↗
FY2019	Dec 31, 2019	10,496	-14.1%	Form 10-K (filed 2022-02-25) ↗
FY2018	Dec 31, 2018	12,213	+6.4%	Form 10-K (filed 2019-02-27) ↗
FY2017	Dec 31, 2017	11,478	+4.8%	Form 10-K (filed 2018-02-27) ↗
FY2016	Dec 31, 2016	10,953	+2.6%	SEC Filing ↗
FY2015	Dec 31, 2015	10,677	-19.0%	Form 10-K (filed 2016-02-26) ↗
FY2014	Dec 31, 2014	13,174	+0.3%	Form 10-K (filed 2015-02-27) ↗
FY2013	Dec 31, 2013	13,140	+1.2%	Form 10-K (filed 2014-02-27) ↗
FY2012	Dec 31, 2012	12,990	-5.7%	Form 10-K (filed 2014-02-27) ↗
FY2011	Dec 31, 2011	13,782	–	Form 10-K (filed 2014-02-27) ↗

Cite this data

StockData. (2026). Merck Consolidated EMEA Revenue ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_geo_emea_rev

See every metric in the Merck KPI table. Data updated Oct 26, 2026.